References
- Blenkinsopp A., et al. Patient reporting of suspected adverse drug reactions: A review of published literature and international experience. British Journal of Clinical Pharmacology 2007; 63: 148–156
- Corry P., Pinfold V. Just one percent: The experiences of people using mental health services. 2003, Available from www.rethink.org
- Cosentino M, et al. A 1 year study of drug prescriptions and adverse drug reactions in psychiatric hospital practice. Pharmacoepidemiology and Drug Safety 1996; 5: 374–384
- Cradock J., Young A. S., Sullivan G. The accuracy of medical record documentation in schizophrenia. Journal of Behavioural Health Services & Research 2001; 28: 456–464
- Gibbon S., Khalifa N. Recording adverse drug reactions in a forensic psychiatry unit: How can we improve the standards?. British Journal of Forensic Practice 2005; 3: 7–11
- Grohmann R., et al. The AMUP study for drug surveillance in psychiatry: A summary of inpatient data. Pharmacopsychiatry 2004; 37(Suppl. 1)S16–26
- Lam Y. W. F., et al. Comparative assessment of antipsychotic adherence by concentration monitoring, pill count and self report. Schizophrenia Research 2003; 60: 313
- NHS Litigation Authority. Clinical Negligence Scheme for Trusts: Mental health and learning disability: Clinical risk management standards. 2006, http://www.nhsla.com
- Scobie S., et al. With safety in mind: Mental health services and patient safety. NPSA. 2006, Available from www.npsa.nhs.uk
- World Health Organization. Safety of medicines: A guide to detecting and reporting adverse drug reactions. WHO, Geneva 2002, Available from: http://whqlibdoc.who.int/hq/2002/WHO_EDM_QSM_2002.2.pdf